Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Minority Interest: 2015-2025

Historic Minority Interest for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2025 value amounting to $12.9 million.

  • HUTCHMED (China)'s Minority Interest rose 7.75% to $12.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $12.9 million, marking a year-over-year increase of 7.75%. This contributed to the annual value of $26.5 million for FY2022, which is 49.63% down from last year.
  • As of Q2 2025, HUTCHMED (China)'s Minority Interest stood at $12.9 million, which was up 7.75% from $11.9 million recorded in Q2 2024.
  • Over the past 5 years, HUTCHMED (China)'s Minority Interest peaked at $52.6 million during Q4 2021, and registered a low of $11.9 million during Q2 2024.
  • Its 3-year average for Minority Interest is $14.3 million, with a median of $12.9 million in 2025.
  • Per our database at Business Quant, HUTCHMED (China)'s Minority Interest soared by 80.35% in 2022 and then tumbled by 65.51% in 2023.
  • HUTCHMED (China)'s Minority Interest (Quarterly) stood at $52.6 million in 2021, then slumped by 49.63% to $26.5 million in 2022, then slumped by 65.51% to $18.0 million in 2023, then crashed by 33.62% to $11.9 million in 2024, then climbed by 7.75% to $12.9 million in 2025.
  • Its last three reported values are $12.9 million in Q2 2025, $11.9 million for Q2 2024, and $18.0 million during Q2 2023.